Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
12/02/2003 | US6656718 Modified carboxypeptidase enzymes and their use |
12/02/2003 | US6656717 Cyclic AMP phosphodiesterase isoforms and methods of use |
12/02/2003 | US6656716 Polypeptide fragments of human PAK5 protein kinase |
12/02/2003 | US6656715 Isolated nucleic acid encoding a polypeptide which catalyzes the oxidation of o-dianisidine; useful in replacing synthetic organic chemistry reactions to make active intermediates or products, such as pesticides and antibiotics |
12/02/2003 | US6656713 Compounds and methods for modulating activation of NF-κB |
12/02/2003 | US6656711 Fermentative preparation process for and crystal forms of cytostatics |
12/02/2003 | US6656709 Methods of increasing the production of cobalamins using cob gene expression |
12/02/2003 | US6656708 Splice variant; expression vectors |
12/02/2003 | US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides |
12/02/2003 | US6656706 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes |
12/02/2003 | US6656705 Sciellin and uses thereof |
12/02/2003 | US6656700 Isoforms of human pregnancy-associated protein-E |
12/02/2003 | US6656681 Polycystic kidney disease 12 gene and uses thereof |
12/02/2003 | US6656679 Heat shock protein-based vaccines and immunotherapies |
12/02/2003 | US6656479 Protects a mammal against neosporosis |
12/02/2003 | US6656475 Modulating growth of muscle or adipose tissue in eukaryotic organism using agent that affects myostatin signal transduction |
12/02/2003 | CA2085308C Dibasic endoprotease fused to endoplasmic reticulum retention signal and use thereof |
12/02/2003 | CA2051562C Bacillus thuringiensis isolates active against dipteran pests |
11/27/2003 | WO2003097873A2 Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications |
11/27/2003 | WO2003097871A2 Marker molecules associated with lung tumors |
11/27/2003 | WO2003097856A2 Plating media |
11/27/2003 | WO2003097853A2 Method of screening anti-bacterial agents for effectiveness in treating persistent intracellular infections |
11/27/2003 | WO2003097846A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
11/27/2003 | WO2003097845A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
11/27/2003 | WO2003097838A1 Plasmid stabilisation in vivo |
11/27/2003 | WO2003097825A2 Novel phospholipases and uses thereof |
11/27/2003 | WO2003097821A1 Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide |
11/27/2003 | WO2003097817A1 Novel microorganism acidovorax temperans and uses therefor |
11/27/2003 | WO2003097816A1 Method of effecting lysis of acid-fast bacteria and method of performing gene amplification or detection therewith |
11/27/2003 | WO2003097810A2 Nitrilases, nucleic acids encoding them and methods for making and using them |
11/27/2003 | WO2003097798A2 Carotene synthase gene and uses therefor |
11/27/2003 | WO2003097795A2 Constitutively translocating cell line |
11/27/2003 | WO2003097686A1 Novel protein, its dna and use thereof |
11/27/2003 | WO2003097091A2 Glucan-based vaccines |
11/27/2003 | WO2003096969A2 Novel lambda phage display system and the process |
11/27/2003 | WO2003096812A1 Regulated attenuation of live vaccines to enhance cross protective immunogenicity |
11/27/2003 | WO2003080570A3 Recombinant expression vectors for functional nav1.9 sodium channels |
11/27/2003 | WO2003078613A3 Serine hydroxymethyltransferase as a target for herbicides |
11/27/2003 | WO2003078568A3 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
11/27/2003 | WO2003076469A3 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature |
11/27/2003 | WO2003075669A3 Food fermentation with lactic acid bacteria |
11/27/2003 | WO2003072594A3 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity |
11/27/2003 | WO2003070765A3 Growth hormone fusion protein |
11/27/2003 | WO2003068802A3 Materials and methods for preparing dimeric growth factors |
11/27/2003 | WO2003066545A3 Amino acids factory |
11/27/2003 | WO2003064622A3 Aggrecanase molecules |
11/27/2003 | WO2003062270A3 Fluorescent protein from aequorea coerulscens and uses therof |
11/27/2003 | WO2003056020A3 Expression vectors and promoters for heterologous gene expression |
11/27/2003 | WO2003043986A3 Polypeptides of moraxella (branhamella) catarrhalis |
11/27/2003 | WO2003042249A3 Peptide purification by means of metal ion affinity chromatography |
11/27/2003 | WO2003036255A3 Method for formulating a glucose oxidase enzyme with a desired property or properties and a glucose oxidase enzyme with the desired property |
11/27/2003 | WO2003035696A3 Humanized antibodies against icam-1, their production and uses |
11/27/2003 | WO2003034275A3 Chimeric glycosylphosphatidylinositol containing peptides |
11/27/2003 | WO2003031578A3 Mammalian c-type lectins |
11/27/2003 | WO2003030824A3 Methods and compositions for treating dermal lesions |
11/27/2003 | WO2003029464A3 Genes associated with mast cell activation |
11/27/2003 | WO2003027147A3 Human coagulation factor vii polypeptides |
11/27/2003 | WO2003022868A3 Metal binding proteins and associated methods |
11/27/2003 | WO2003020759A3 A caspase- 8 binding protein, its preparation and use |
11/27/2003 | WO2003018778A3 Method for preparing a freeze-dried composition containing lactic acid bacteria with enhanced bacterial viability and activity during storage at room temperature and resulting composition |
11/27/2003 | WO2003018636A3 Chimaeric peptides of insulin, their compositions and use in treating diabetes |
11/27/2003 | WO2003016481A3 Novel human collagen proteins and polynucleotides encoding the same |
11/27/2003 | WO2003010200A3 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus |
11/27/2003 | WO2003010195A3 Novel compounds |
11/27/2003 | WO2002102299A3 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
11/27/2003 | WO2002097075B1 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties |
11/27/2003 | WO2002092801A3 Methods and compositions for making emamectin |
11/27/2003 | WO2002092771A3 Specific binding proteins and uses thereof |
11/27/2003 | WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene |
11/27/2003 | WO2002086113A3 Enzyme and snp marker for disease |
11/27/2003 | WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene |
11/27/2003 | WO2002074964A3 Polypeptides derived from rna polymerases and use thereof |
11/27/2003 | WO2002072856A3 Improved process for converting nitriles to carboxylic acids using nitrilase |
11/27/2003 | WO2002072838A3 A process for the fermentative preparation of d-pantothenic acid and/or its salts |
11/27/2003 | WO2002072821A3 Method for indentification of cdnas encoding signal peptides |
11/27/2003 | WO2002072632A3 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
11/27/2003 | WO2002068459A3 Non aggregating fluorescent proteins and methods for using the same |
11/27/2003 | WO2002064791A3 Proteins and nucleic acids encoding same |
11/27/2003 | WO2002064624A8 Improved method for production of secreted proteins in fungi |
11/27/2003 | WO2002063010A3 Method of producing recombinant antibodies against tumors |
11/27/2003 | WO2002061109A3 Yeast strains autonomously producing steroids |
11/27/2003 | WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
11/27/2003 | WO2002050113A3 Interleukin-1 related gene and protein |
11/27/2003 | WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
11/27/2003 | WO2002048368A3 Proteins associated with cell growth, differentiation, and death |
11/27/2003 | US20030221209 Modified proteinase inhibitors |
11/27/2003 | US20030221205 Olfactory and pheromones G-protein coupled receptors |
11/27/2003 | US20030220491 Novel human transporter proteins and polynucleotides encoding the same |
11/27/2003 | US20030220489 29 human secreted proteins |
11/27/2003 | US20030220488 Comprises peptide for diagnosing and treating cancer, hypoxia, blood and immunological disorders |
11/27/2003 | US20030220484 Modified ciliary neurotrophic factors |
11/27/2003 | US20030220480 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
11/27/2003 | US20030220472 Treatment of hematopoietic cell deficiencies, stimulating the production of hematopoietic cells, recombinant DNA sequence encodes or vector expression of the muteins; side effect reduction |
11/27/2003 | US20030220405 DNA encoding an epsilon, epsilon-lycopene cyclase from romaine lettuce |
11/27/2003 | US20030220379 Fermentative preparation process for and crystal forms of cytostatics |
11/27/2003 | US20030220306 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity |
11/27/2003 | US20030220256 Truncated 24kDa basic fibroblast growth factor |
11/27/2003 | US20030220239 Epitope sequences |
11/27/2003 | US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder |
11/27/2003 | US20030219902 Methods and vectors for facilitating site-specific recombination |